comparemela.com
Home
Live Updates
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies : comparemela.com
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies
Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 -- Biogen Inc. and... | January 4, 2023
Related Keywords
Cambridge
,
Cambridgeshire
,
United Kingdom
,
Priya Singhal
,
Aurora Krause
,
Jack Cox
,
Walter Gilbert
,
Charles Weissmann
,
Heinz Schaller
,
Kenneth Murray
,
Linkedin
,
Twitter
,
Ionis Pharmaceuticals Inc
,
Drug Administration
,
Biogen Inc
,
Nasdaq
,
Exchange Commission
,
Youtube
,
Facebook
,
Alcyone Therapeutics
,
Breakthrough Device Designation
,
Interim Head
,
Chief Executive Officer
,
Delivery Platform
,
Ionis Pharmaceuticals
,
Important Safety Information
,
Prescribing Information
,
Sir Kenneth Murray
,
Nobel Prize
,
Abigail Wexner Research Institute
,
Nationwide Children
,
Charcot Marie Tooth
,
Safe Harbor
,
Private Securities Litigation Reform Act
,
Biogen Inc Stock Exchange
,
News
,
Information
,
Press Release
,
Hecaflex
,
Us
,
N
,
Implantable
,
Medical
,
Device
,
Development
,
Or
,
Ntrathecal
,
Drug
,
Delivery
,
End
,
023
,
Iogen Biib Us09062x1037
,
comparemela.com © 2020. All Rights Reserved.